Victrio (Canada)This page contains information on Victrio for veterinary use.
The information provided typically includes the following:
- Victrio Indications
- Warnings and cautions for Victrio
- Direction and dosage information for Victrio
VictrioThis treatment applies to the following species:
See productdata.aphis.usda.gov for a summary of the studies approved by the USDA for licensing this product. The package insert may also contain additional information developed by the licensee.
For In Ovo Administration to 18-Day-Old Embryonated Eggs
FOR VETERINARY USE ONLY
READ IN FULL
VICTRIO is a bacterial-produced plasmid DNA with a lipsome carrier to stimulate the innate immune system in poultry. The stimulation of the innate immune system has been shown to provide a potent, rapid, nonspecific, protective response to infections due to Escherichia coli.
The lyophilized product is packaged with two different sterile diluents. Diluent A is used to reconstitute the lyophilized cake and Diluent B is used for further dilution to final use concentration, OR the reconstituted cake may be combined with Boehringer Ingelheim Animal Health USA MAREK’S DISEASE VACCINE (HVT + SB1), as described below.
This product has been shown to be effective for the treatment of 18- to 19-day-old embryonated chicken eggs against post-hatch mortality associated with Escherichia coli. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
IMPORTANT STORAGE CONDITIONS
Store refrigerated (2°C to 8°C)
DO NOT FREEZE.
Stability has been demonstrated for at least 8 hours after reconstitution if Diluent A is refrigerated and sterility is maintained.
Diluent B can be stored at room temperature 68 to 77°F or 20 to 25°C.
For in ovo administration, this product may be combined with Boehringer Ingelheim Animal Health USA MAREK’S DISEASE VACCINE (HVT + SB1).
PREPARATION OF THE PRODUCT
This product requires a two-step mixing process that must be completed in the appropriate order.
Step 1: Draw entire contents of Diluent A vial (gold cap) into a syringe.
Step 2: Reconstitute the lyophilized cake (brown cap) with entire contents of Diluent A vial (gold cap).
Step 3: Swirl gently to complete resuspension of the cake.
Step 4: Transfer entire contents of brown cap vial into Diluent B bag. Mix the contents of the diluent bag by swirling and inverting.
Step 4: Transfer entire contents of brown cap vial into Boehringer Ingelheim Animal Health USA MAREK’S DISEASE VACCINE (HVT + SB1) diluent. Volume of diluent should correspond to 200 mL diluent per each 4,000 doses of DNA Immunostimulant.
METHOD OF ADMINISTRATION
Inject each 18-day-old embryonated egg with a full dose (0.05 mL). Use entire contents of vial once first opened.
Do not administer within 21 days of slaughter.
Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician.
Contains no antibiotics and no preservatives.
Vials of 4,000 and 16,000 doses.
Diamond Animal Health, Inc., Des Moines, IA 50327
Made in U.S.A.
Elanco Canada Limited, 150 Research Lane, Suite 120, Guelph, Ontario N1G 4T2
This product is based on technology developed by Juvaris BioTherapeutics and is patent protected. Animal Health applications are being exclusively developed by Elanco and are the subject of Elanco patent applications.
Victrio, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Every effort has been made to ensure the accuracy of the Victrio information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2021 Animalytix LLC. Updated: 2021-10-04